Product NDC: | 21695-108 |
Proprietary Name: | Protonix |
Non Proprietary Name: | pantoprazoel sodium |
Active Ingredient(s): | 40 mg/1 & nbsp; pantoprazoel sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 21695-108 |
Labeler Name: | Rebel Distributors Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020987 |
Marketing Category: | NDA |
Start Marketing Date: | 20010828 |
Package NDC: | 21695-108-15 |
Package Description: | 15 TABLET, DELAYED RELEASE in 1 BOTTLE (21695-108-15) |
NDC Code | 21695-108-15 |
Proprietary Name | Protonix |
Package Description | 15 TABLET, DELAYED RELEASE in 1 BOTTLE (21695-108-15) |
Product NDC | 21695-108 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | pantoprazoel sodium |
Dosage Form Name | TABLET, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20010828 |
Marketing Category Name | NDA |
Labeler Name | Rebel Distributors Corp |
Substance Name | PANTOPRAZOLE SODIUM |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |